Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Short term Debt (2016 - 2025)

Fresenius Medical Care AG (FMS) has 16 years of Short term Debt data on record, last reported at $1.9 billion in Q4 2025.

  • For Q4 2025, Short term Debt rose 202.21% year-over-year to $1.9 billion; the TTM value through Dec 2025 reached $1.9 billion, up 202.21%, while the annual FY2025 figure was $1.8 billion, 189.6% up from the prior year.
  • Short term Debt reached $1.9 billion in Q4 2025 per FMS's latest filing, up from $614.7 million in the prior quarter.
  • Across five years, Short term Debt topped out at $1.9 billion in Q4 2025 and bottomed at $614.7 million in Q4 2024.
  • Average Short term Debt over 4 years is $986.2 million, with a median of $736.1 million recorded in 2021.
  • Peak YoY movement for Short term Debt: tumbled 36.44% in 2021, then surged 202.21% in 2025.
  • A 4-year view of Short term Debt shows it stood at $764.1 million in 2021, then fell by 7.33% to $708.1 million in 2022, then fell by 13.19% to $614.7 million in 2024, then soared by 202.21% to $1.9 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $1.9 billion in Q4 2025, $614.7 million in Q4 2024, and $708.1 million in Q4 2022.